My 2021 schedule
(This section will be updated as my speaking commitments for 2021 are confirmed. If you are a Member of Simple and Practical Medical Education and will be at any of these meetings, I would love to meet you!)
March 14, 2021
Psychopharmacology Update: State-of-the-Art 2021 (virtual)
Spring CME conference of the American Society of Clinical Psychopharmacology (ASCP)
Topic: Psychopharmythology: Widely-held beliefs (about important issues) that are just not true
October 23, 2021
NEI Synapse Virtual Half-Day
Topic: What’s Shakin’? An Update on the Diagnosis and Treatment of Movement Disorders
My 2020 schedule
In 2020, I was scheduled to do the following talks. The ones that were scheduled for April and May were canceled due to the COVID-19 pandemic and the ones in Fall 2020 were held virtually.
January 22 to 25, 2020
Annual National Conference of the Indian Psychiatric Society (ANCIPS), Kolkata, India
Topics:
1. Recent advances in treatment-resistant depression (CME lecture)
2. Psychopharmacology in the Medically Ill (In the workshop Place of psychotropics in the universe of pharmacology)
April 4, 2020
POSTPONED Simple and Practical Medical Education’s Live Course, New York, New York
Assessment and Management of Treatment-resistant depression (with Michael E. Thase, MD, and Joseph F. Goldberg, MD)
April 17 to 19, 2020
CANCELED NEI Synapse, Las Vegas, Nevada
April 25 to 29, 2020
CANCELED Annual Meeting of the American Psychiatric Association, Philadelphia, Pennsylvania
Topic: General Session 1585–Prevention and Management of Side Effects to Reduce Suffering, Facilitate Medication Adherence, and Improve Outcomes (with Joseph F. Goldberg, MD)
May 17 to 20, 2020
CANCELED Oasis 2020 Child & Adolescent Psychiatry Conference, Isle of Palms, South Carolina
Topics:
1. ADHD Out of the Nest: Management During College Transition
2. ADHD: Practical Management of ADHD Medication Side-Effects
September 12, 2020
Psych Congress 2020 virtual conference
Topic: Systematic Strategies for Managing Common Side Effects (Instead of Stopping or Switching the Medication)
October 8, 2020
Oasis 2020 Psychiatry virtual conference
Topics:
1. Managing common and severe adverse drug effects
2. Depression: Update on the management and treatment
3. Bipolar disorders: Treating complex cases
October 15 to 17, 2020
Annual Psychiatric Times® World CME virtual conference
Topics:
1. What Pharmacogenomic Testing Can and Cannot Tell Us: A Practical Guide
2. Major depressive disorder: Clinical conundrums and commentary
November 5 to 8, 2020
NEI Max virtual conference
Topics:
1. Innumerable drug interactions! Realistic solutions for this frustrating clinical problem
2. Grandma might fall! Identifying and managing orthostatic hypotension due to psychiatric medications
3. Food, drink, and meds: Important interactions between food, beverages, and psychiatric medications
4. Addressing the Intolerable: Practical Strategies to Mitigate Psychotropic Side Effects
5. Using rating scales to enhance clinical practice
My 2019 schedule
April 27 and 28, 2019
NEI Synapse, Asheville, North Carolina
Topics:
1. Managing Common Side Effects That Lead to Non-Adherence
2. The Mimics: Common Non-Psychiatric Conditions that May Present with Psychiatric Symptoms.
May 1, 2019
Oasis 2019 Child & Adolescent Psychiatry Conference, Isle of Palms, SC
Topics:
1. Management of Common Side Effects in Child and Adolescent Psychiatry
2. Fundamentals of Direct-Pay Model
August 25, 2019
International Summit on MAOIs for Depression, Mumbai, India
Topic: Using Tranylcypromine in Difficult-to-Treat Depression: A Practical Guide
October 3 to 6, 2019
Oasis 2019 Psychiatry Conference, La Jolla, California
Topics:
1. Advanced Treatment Strategies for Bipolar Depression
2. Advanced Treatment Strategies for Bipolar Disorder: Mania and Maintenance Treatment
3. Pharmacogenomic Testing to Predict (and Reduce) Side Effects of Psychotropic Medications
November 10, 2019
NEI Congress, Colorado Springs, Colorado
Topic: Psychopharmythology: Beliefs Widely Held by Psychopharmacologists that are Actually Not True
My 2018 schedule
Sunday, March 25, 2018
American Society for Clinical Psychopharmacology’s Spring meeting Psychopharmacology Update: State-of-the-Art 2018, University of California, Los Angeles (UCLA) Luskin Center, Los Angeles, California.
Monday, May 7, 2018
Annual meeting of the American Psychiatric Association, New York, New York.
Wednesday, May 30, 2018
Keynote speaker. 6th Annual Psychiatry Symposium: Update on Depressive Disorders, Jersey Shore University Medical Center, Neptune, New Jersey.
Thursday, May 31, 2018
American Society for Clinical Psychopharmacology’s annual meeting. Miami Beach, Florida.
Sunday, October 14, 2018
MASTERPSYCH 2018 Live Conference, Santa Barbara, California.
Friday, November 2, 2018
Southern California Kaiser Permanente Symposium, California.
November 7 – 11, 2018
NEI Congress, Orlando, Florida
Below are some topics on which I have done talks at different institutions. The feedback I have received is that these talks were very clear and clinically useful. To invite me to give one of these talks at your institution or to request a talk on a different topic, email me at mago@simpleandpractical.com.
Note: These talks are not necessarily listed in the order of importance or my preference.
Practical management of the side effects of medications used to treat ADHD
Ordering and interpreting liver function tests: A simplified guide for mental health clinicians (with examples)
Ordering and interpreting thyroid function tests: A simplified guide for mental health clinicians (with examples)
Advanced strategies for managing treatment-resistant bipolar depression
Practical Management of Common Side Effects of Psychotropic Medications
(Covers sexual dysfunction, excessive sweating, nausea, dry mouth, orthostatic hypotension, etc)
Pharmacogenomic Testing to Predict and Reduce Side Effects of Psychotropic Medications
Stop the Roller Coaster: Managing Treatment-Resistant Bipolar Disorder
Psychopharmythology: Some beliefs widely held by psychopharmacologists that are actually not true
Controversies in the treatment of Obsessive-Compulsive Disorder
Medically Serious Adverse Effects of Antidepressant Medications
(Covers bleeding, hyponatremia, seizures, QT prolongation, etc)
Common Medical Conditions that Present with Psychiatric Symptoms but are Commonly Missed by Us
(This covers Sleep Apnea, Polycystic Ovarian Syndrome, and Others)
Practical management of the side effects of medications used to treat ADHD
Understanding and evaluating executive dysfunction—the central problem in adults with ADHD
Hepatic function tests: A practical guide for mental health clinicians
It’s not really insomnia! Understanding and managing Delayed Sleep Phase Disorder
Career guidance workshop: I have worked in a variety of settings — inpatient unit (4 years), consultation-liaison psychiatry (3 years), academics/ clinical trials (13 years), and private practice (3 years).
Overview of Non-stimulant Pharmacotherapy of ADHD (This covers atomoxetine, guanfacine, clonidine, bupropion, modafinil, TCAs, etc)
Using Rating Scales to Enhance Clinical Practice
Evaluation and Management of Antidepressant-Induced Sexual Dysfunction
A Practical Guide to Clinically-Important Drug Interactions
Clinicians’ Guide to Reading and Applying Clinical Trial Results(A simple guide for those without a research background who want to be able to empowered to understand the basics when they come across a clinical trial.)
Psychopharmacology of Mood Disorders in Women
The Internet as a Tool in Clinical Practice(A series of websites are amazingly useful yet unknown to most clinicians. This talk is simple but extremely useful for clinicians and – trust me–has been very much appreciated by the audience.)
Adult ADHD: Diagnosis and Assessment
The Latest Antidepressants: A Review for Clinicians
Cardiovascular Adverse Effects of Newer Antidepressants(excluding TCAs and MAOIs)
Adult ADHD: Pages from Clinical Experience(Especially suited for an audience that is not yet convinced that it is extremely important that we diagnose and treat ADHD. Includes case vignettes and covers key principles of assessment.)
Different Sources of Evidence: When, Where, and How(Covers when and how to find and use practice guidelines vs. systematic reviews/ meta-analyses vs. clinical trials.)
Adverse effects of mood stabilizers and their effect on nonadherence
Leave a Reply: